# RPS6KA5

## Overview
RPS6KA5 is a gene that encodes the protein ribosomal protein S6 kinase A5, commonly referred to as MSK1. MSK1 is a serine/threonine kinase that plays a pivotal role in cellular signaling, particularly within the MAPK/ERK pathway. This protein is characterized by its two kinase domains, which are integral to its function in phosphorylating various substrates, including transcription factors and histones, thereby influencing gene expression and cellular responses to external stimuli (Eno202114q32.11; Modi2019A). MSK1 is notably involved in processes such as synaptic plasticity and cellular stress response, highlighting its importance in brain function and homeostasis (Corrêa2012MSK1). The expression and activity of RPS6KA5 have been studied in the context of various diseases, including major depressive disorder and certain cancers, where it may serve as a biomarker or therapeutic target (Zhang2023Establishment; Xu2022RPS6KA5).

## Structure
RPS6KA5, also known as MSK1, is a serine/threonine kinase that plays a role in cellular signaling pathways, particularly the MAPK/ERK pathway. The protein contains two kinase domains: an N-terminal kinase domain and a C-terminal kinase domain, which are characteristic of the AGC kinase family (Modi2019A). These domains are involved in the phosphorylation of substrates, a common post-translational modification that regulates the protein's activity (Eno202114q32.11).

RPS6KA5 is known to form homodimers or heterodimers, contributing to its quaternary structure (Modi2019A). The protein is highly expressed in the cerebellum and cerebral hemisphere, indicating its importance in brain function (Eno202114q32.11). Although specific details on the secondary and tertiary structures are not provided, the presence of two kinase domains suggests a complex folding pattern typical of kinases, which often includes alpha helices and beta sheets.

The protein may exist in different isoforms due to alternative splicing, which can affect its function and interactions (Modi2019A). Despite its involvement in critical signaling pathways, no variants of RPS6KA5 have been directly associated with human disorders to date (Eno202114q32.11).

## Function
RPS6KA5, also known as MSK1, is a serine/threonine kinase that plays a significant role in cellular signaling pathways. It is activated by the ERK1/2 and p38 MAPK pathways, which are crucial for responding to mitogens and cellular stress (Eno202114q32.11). MSK1 is involved in the phosphorylation of transcription factors such as CREB and ATF1, as well as histone H3, which are essential for regulating gene expression (Corrêa2012MSK1). This phosphorylation activity occurs primarily in the nucleus, where MSK1 influences processes like cell growth, differentiation, and stress response (Corrêa2012MSK1).

MSK1 is also implicated in synaptic plasticity, particularly in homeostatic and experience-dependent changes. It is necessary for synaptic strength upregulation in response to environmental enrichment and activity deprivation, acting as a key regulator in synaptic strength regulation (Corrêa2012MSK1). MSK1's role in synaptic plasticity involves the BDNF/TrkB/MAPK signaling pathway, where it acts as a molecular homeostat linking receptor activation to the induction of plasticity-related proteins (Corrêa2012MSK1). These functions highlight MSK1's critical role in cellular responses to external stimuli and its involvement in maintaining cellular homeostasis.

## Clinical Significance
Alterations in the expression of the RPS6KA5 gene have been associated with various diseases and conditions. In the context of major depressive disorder (MDD), RPS6KA5 methylation has been studied as a potential biomarker for predicting treatment response in adolescent patients. Although RPS6KA5 is differentially methylated in MDD patients compared to healthy controls, its methylation status does not directly correlate with the severity of depression or chronic childhood stress (Xu2022RPS6KA5).

In cancer research, RPS6KA5 has been implicated in the prognosis of kidney renal clear cell carcinoma (KIRC). High expression levels of RPS6KA5 are associated with a better prognosis in KIRC, suggesting its role as a protective factor in disease progression (Zhang2023Establishment). Conversely, in colorectal cancer (CRC), alterations in RPS6KA5 expression are part of gene signatures used to identify higher-risk patients with a high rate of relapse (Ahluwalia2021The).

RPS6KA5 is also involved in the MAPK signaling pathway, which is crucial for various cellular processes, including those related to cancer progression. Its role in this pathway has been noted in studies of leiomyoma, where it is overexpressed in myoma tissue, suggesting a potential involvement in fibrotic conditions (Lemeer2014Quantitative).


## References


[1. (Corrêa2012MSK1) Sonia A. L. Corrêa, Christopher J. Hunter, Oleg Palygin, Sandrine C. Wauters, Kirsty J. Martin, Colin McKenzie, Kim McKelvey, Richard G. M. Morris, Yuriy Pankratov, J. Simon C. Arthur, and Bruno G. Frenguelli. Msk1 regulates homeostatic and experience-dependent synaptic plasticity. The Journal of Neuroscience, 32(38):13039–13051, September 2012. URL: http://dx.doi.org/10.1523/jneurosci.0930-12.2012, doi:10.1523/jneurosci.0930-12.2012. This article has 67 citations.](https://doi.org/10.1523/jneurosci.0930-12.2012)

[2. (Ahluwalia2021The) Pankaj Ahluwalia, Ravindra Kolhe, and Gagandeep K. Gahlay. The clinical relevance of gene expression based prognostic signatures in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1875(2):188513, April 2021. URL: http://dx.doi.org/10.1016/j.bbcan.2021.188513, doi:10.1016/j.bbcan.2021.188513. This article has 54 citations.](https://doi.org/10.1016/j.bbcan.2021.188513)

[3. (Eno202114q32.11) Celeste C. Eno, Jesper Graakjaer, Dea Svaneby, Mathilde Nizon, Jessica Kianmahd, Rebecca Signer, Julian A. Martinez‐Agosto, and Fabiola Quintero‐Rivera. 14q32.11 microdeletion including <scp>calm1</scp>, <scp>ttc7b</scp>, <scp>psmc1</scp>, and <scp>rps6ka5</scp>: a new potential cause of developmental and language delay in three unrelated patients. American Journal of Medical Genetics Part A, 185(5):1519–1524, February 2021. URL: http://dx.doi.org/10.1002/AJMG.A.62117, doi:10.1002/ajmg.a.62117. This article has 6 citations.](https://doi.org/10.1002/AJMG.A.62117)

[4. (Lemeer2014Quantitative) Simone Lemeer, Amin Moghaddas Gholami, Zhixiang Wu, and Bernhard Kuster. Quantitative proteome profiling of human myoma and myometrium tissue reveals kinase expression signatures with potential for therapeutic intervention. PROTEOMICS, 15(2–3):356–364, December 2014. URL: http://dx.doi.org/10.1002/pmic.201400213, doi:10.1002/pmic.201400213. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/pmic.201400213)

[5. (Xu2022RPS6KA5) Peiwei Xu, Yuanmei Tao, Hang Zhang, Meijiang Jin, Hanmei Xu, Shoukang Zou, Fang Deng, Lijuan Huang, Hong Zhang, Xiaolan Wang, Xiaowei Tang, Zaiquan Dong, Yanping Wang, Li Yin, and Xueli Sun. Rps6ka5 methylation predict response to 6-week treatment for adolescent mdd patients. BMC Psychiatry, August 2022. URL: http://dx.doi.org/10.1186/s12888-022-04196-4, doi:10.1186/s12888-022-04196-4. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12888-022-04196-4)

[6. (Zhang2023Establishment) Peizhi Zhang, Jiayi Li, Zicheng Wang, Leizuo Zhao, Jiechuan Qiu, Yingkun Xu, Guangzhen Wu, and Qinghua Xia. Establishment of a new prognostic risk model of mapk pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis. Frontiers in Oncology, March 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1077309, doi:10.3389/fonc.2023.1077309. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1077309)

[7. (Modi2019A) Vivek Modi and Roland L. Dunbrack. A structurally-validated multiple sequence alignment of 497 human protein kinase domains. Scientific Reports, December 2019. URL: http://dx.doi.org/10.1038/s41598-019-56499-4, doi:10.1038/s41598-019-56499-4. This article has 93 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-56499-4)